OBJECTIVE: To determine the effect of insulin for the management of hyperglycaemia in non-diabetic patients presenting with acute coronary syndrome. METHODS: An observational study from the MINAP (National Audit of Myocardial Infarction Project) database during 2003-5 in 201 hospitals in England and Wales. Patients were those with a final diagnosis of troponin-positive acute coronary syndrome who were not previously known to have diabetes mellitus and whose blood glucose on admission was > or = 11 mmol/l. The main outcome measure was death at 7 and 30 days. RESULTS: Of 38,864 patients who were not previously known to be diabetic, 3835 (9.9%) had an admission glucose > or = 11 mmol/l. Of patients having a clear treatment strategy, 36% received diabetic treatment (31% with insulin). Mortality at 7 and 30 days was 11.6% and 15.8%, respectively, for those receiving insulin, and 16.5% and 22.1%, respectively, for those who did not. Compared with those who received insulin, after adjustment for age, gender, co-morbidities and admission blood glucose concentration, patients who were not treated with insulin had a relative increased risk of death of 56% at 7 days and 51% at 30 days (HR 1.56, 95% CI 1.22 to 2.0, p<0.001 at 7 days; HR 1.51, 95% CI 1.22 to 1.86, p<0.001 at 30 days). CONCLUSION: In non-diabetic patients with acute coronary syndrome and hyperglycaemia, treatment with insulin was associated with a reduction in the relative risk of death, evident within 7 days of admission, which persists at 30 days.
OBJECTIVE: To determine the effect of insulin for the management of hyperglycaemia in non-diabeticpatients presenting with acute coronary syndrome. METHODS: An observational study from the MINAP (National Audit of Myocardial Infarction Project) database during 2003-5 in 201 hospitals in England and Wales. Patients were those with a final diagnosis of troponin-positive acute coronary syndrome who were not previously known to have diabetes mellitus and whose blood glucose on admission was > or = 11 mmol/l. The main outcome measure was death at 7 and 30 days. RESULTS: Of 38,864 patients who were not previously known to be diabetic, 3835 (9.9%) had an admission glucose > or = 11 mmol/l. Of patients having a clear treatment strategy, 36% received diabetic treatment (31% with insulin). Mortality at 7 and 30 days was 11.6% and 15.8%, respectively, for those receiving insulin, and 16.5% and 22.1%, respectively, for those who did not. Compared with those who received insulin, after adjustment for age, gender, co-morbidities and admission blood glucose concentration, patients who were not treated with insulin had a relative increased risk of death of 56% at 7 days and 51% at 30 days (HR 1.56, 95% CI 1.22 to 2.0, p<0.001 at 7 days; HR 1.51, 95% CI 1.22 to 1.86, p<0.001 at 30 days). CONCLUSION: In non-diabeticpatients with acute coronary syndrome and hyperglycaemia, treatment with insulin was associated with a reduction in the relative risk of death, evident within 7 days of admission, which persists at 30 days.
Authors: Ischa Stranders; Michaela Diamant; Rogier E van Gelder; Hugo J Spruijt; Jos W R Twisk; Robert J Heine; Frans C Visser Journal: Arch Intern Med Date: 2004-05-10
Authors: S Hadjadj; D Coisne; G Mauco; S Ragot; F Duengler; P Sosner; F Torremocha; D Herpin; R Marechaud Journal: Diabet Med Date: 2004-04 Impact factor: 4.359
Authors: J A Lipton; R J Barendse; R T Van Domburg; A F L Schinkel; H Boersma; M I Simoons; K M Akkerhuis Journal: Eur Heart J Acute Cardiovasc Care Date: 2013-05-09
Authors: Sean Brennan; Simona Esposito; Muhammad I M Abdelaziz; Christopher A Martin; Samir Makwana; Mark W Sims; Iain B Squire; Parveen Sharma; Amy E Chadwick; Richard D Rainbow Journal: Front Cardiovasc Med Date: 2022-09-07
Authors: Meghan Sauvé; Kiwon Ban; M Abdul Momen; Yu-Qing Zhou; R Mark Henkelman; Mansoor Husain; Daniel J Drucker Journal: Diabetes Date: 2010-01-22 Impact factor: 9.461